{"hands_on_practices": [{"introduction": "The Pyruvate Dehydrogenase Complex (PDC) performs one of the most critical reactions in central metabolism: the oxidative decarboxylation of pyruvate. To truly understand its regulation and function, one must first have an unshakable grasp of this core chemical transformation. This practice utilizes isotopic labeling, a classic biochemical technique, to guide you through the reaction mechanism and trace the fate of each carbon atom from substrate to product, reinforcing the fundamental chemistry catalyzed by the E1 subunit [@problem_id:2595865].", "problem": "A mitochondrial preparation is supplied with pyruvate in which the carboxyl carbon is radiolabeled, denoted as $\\left[1\\text{-}{}^{14}\\mathrm{C}\\right]$pyruvate. The preparation contains an active pyruvate dehydrogenase complex (PDC; pyruvate dehydrogenase, dihydrolipoyl transacetylase, and dihydrolipoyl dehydrogenase), with thiamine pyrophosphate (TPP; thiamine pyrophosphate), lipoamide, flavin adenine dinucleotide (FAD; flavin adenine dinucleotide), nicotinamide adenine dinucleotide ($\\mathrm{NAD}^{+}$; nicotinamide adenine dinucleotide), and coenzyme A (CoA; coenzyme A) present in saturating amounts. Immediately after a single catalytic turnover of the pyruvate dehydrogenase complex (before any entry of acetyl groups into the tricarboxylic acid cycle), you collect and separate the two primary products of the pyruvate dehydrogenase reaction: carbon dioxide ($\\mathrm{CO}_{2}$) and acetyl–CoA. \n\nUsing only the following fundamental bases:\n- The structural definition of pyruvate as $\\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{COO}^{-}$, with carbon numbering $C\\text{-}1$ (carboxyl carbon, $\\mathrm{COO}^{-}$), $C\\text{-}2$ (keto carbonyl), and $C\\text{-}3$ (methyl).\n- The general mechanism of thiamine pyrophosphate–dependent decarboxylation in which the thiazolium ylide adds to a substrate carbonyl and facilitates loss of the carboxyl group as $\\mathrm{CO}_{2}$.\n- The organization of the pyruvate dehydrogenase complex in which the $E1$ component (pyruvate dehydrogenase, TPP dependent) performs decarboxylation, the $E2$ component (dihydrolipoyl transacetylase) transfers the two-carbon fragment to lipoamide and then to CoA, and the $E3$ component (dihydrolipoyl dehydrogenase) reoxidizes lipoamide with $\\mathrm{NAD}^{+}$ as the terminal electron acceptor.\n\nPredict which product will carry the $\\;{}^{14}\\mathrm{C}\\;$ label after this single pass through the pyruvate dehydrogenase complex and justify your choice by mapping the fate of each pyruvate carbon through the $E1$ decarboxylation step and subsequent transfer to acetyl–CoA.\n\nChoose one option:\nA. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in $\\mathrm{CO}_{2}$; the acetyl–CoA is unlabeled. \n\nB. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in the carbonyl carbon of acetyl–CoA. \n\nC. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in the methyl carbon of acetyl–CoA. \n\nD. The $\\;{}^{14}\\mathrm{C}\\;$ label partitions between $\\mathrm{CO}_{2}$ and acetyl–CoA due to equilibration during the $E1$ step.", "solution": "First, the problem statement must be validated for scientific soundness and logical consistency.\n\n**Step 1: Extracted Givens**\n- Substrate: Pyruvate with the carboxyl carbon radiolabeled, $[1\\text{-}{}^{14}\\mathrm{C}]$pyruvate.\n- System: A mitochondrial preparation containing an active pyruvate dehydrogenase complex (PDC), which includes pyruvate dehydrogenase ($E1$), dihydrolipoyl transacetylase ($E2$), and dihydrolipoyl dehydrogenase ($E3$).\n- Cofactors: Thiamine pyrophosphate (TPP), lipoamide, flavin adenine dinucleotide (FAD), nicotinamide adenine dinucleotide ($\\mathrm{NAD}^{+}$), and coenzyme A (CoA) are present in saturating amounts.\n- Experimental Condition: Analysis is performed after a single catalytic turnover, before the products enter the tricarboxylic acid cycle.\n- Products to be analyzed: Carbon dioxide ($\\mathrm{CO}_{2}$) and acetyl–CoA.\n- Required Basis for Solution: The solution must be justified using the structural definition of pyruvate ($\\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{COO}^{-}$, $C\\text{-}1$ being the carboxyl carbon), the general mechanism of TPP-dependent decarboxylation, and the functional organization of the $E1$, $E2$, and $E3$ components of the PDC.\n\n**Step 2: Validation**\nThe problem is well-defined and scientifically grounded. It describes a standard biochemical experiment based on the established mechanism of the pyruvate dehydrogenase complex, a central enzyme in metabolism. All components, cofactors, substrates, and products are correctly identified. The constraints—a single turnover and saturating cofactor concentrations—are clear and serve to isolate the specific reaction in question. The problem is free of internal contradictions, ambiguity, and factual errors. It is a valid scientific question that can be answered rigorously from the provided first principles.\n\n**Step 3: Verdict**\nThe problem is valid. The solution will now be derived.\n\nThe overall chemical transformation catalyzed by the pyruvate dehydrogenase complex is the oxidative decarboxylation of pyruvate to acetyl-CoA and $\\mathrm{CO}_{2}$:\n$$ \\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{COO}^{-} + \\mathrm{CoA}\\text{-}\\mathrm{SH} + \\mathrm{NAD}^{+} \\longrightarrow \\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{S}\\text{-}\\mathrm{CoA} + \\mathrm{CO}_{2} + \\mathrm{NADH} + \\mathrm{H}^{+} $$\nThe problem specifies that the substrate is pyruvate labeled at its carboxyl carbon, $C\\text{-}1$. The structure is therefore:\n$$ \\mathrm{CH}_{3}(C\\text{-}3)\\text{-}\\mathrm{CO}(C\\text{-}2)\\text{-}{}^{14}\\mathrm{COO}^{-}(C\\text{-}1) $$\nTo determine the fate of the ${}^{14}\\mathrm{C}$ label, we must trace the path of each carbon atom through the reaction sequence as it occurs on the three enzymes of the complex.\n\n**Analysis of the Reaction Mechanism:**\n\n1.  **Reaction on Pyruvate Dehydrogenase ($E1$): Decarboxylation**\n    The first step of the catalytic cycle occurs on the $E1$ subunit and involves the cofactor thiamine pyrophosphate (TPP). The catalytically active form of TPP is a carbanion (ylide) which acts as a nucleophile. This TPP ylide attacks the electrophilic carbonyl carbon ($C\\text{-}2$) of pyruvate. This forms a temporary tetrahedral adduct.\n    Critically, the thiazolium ring of TPP acts as an \"electron sink,\" stabilizing the negative charge that develops upon the breaking of the $C\\text{-}1\\text{-}C\\text{-}2$ bond. This bond cleavage results in the release of the carboxyl group ($C\\text{-}1$) as carbon dioxide, $\\mathrm{CO}_{2}$. Since $C\\text{-}1$ is the labeled carbon, the released carbon dioxide molecule will be radioactive: ${}^{14}\\mathrm{CO}_{2}$.\n    $$ \\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}{}^{14}\\mathrm{COO}^{-} \\xrightarrow{E1,\\ TPP} \\left[ \\text{_hydroxyethyl-TPP intermediate_} \\right] + {}^{14}\\mathrm{CO}_{2} $$\n    The remaining two-carbon fragment, derived from $C\\text{-}2$ and $C\\text{-}3$ of pyruvate, is now covalently attached to TPP as a hydroxyethyl group.\n\n2.  **Reaction on Dihydrolipoyl Transacetylase ($E2$): Acetyl Group Transfer**\n    The hydroxyethyl-TPP intermediate is passed to the $E2$ subunit. Here, the hydroxyethyl group is simultaneously oxidized to an acetyl group and transferred to the lipoamide cofactor of $E2$. This forms an acetyl-dihydrolipoamide intermediate.\n    $$ \\left[ \\text{_hydroxyethyl-TPP_} \\right] + \\text{Lipoamide}_{ox} \\longrightarrow \\text{TPP} + \\left[ \\text{_acetyl-dihydrolipoamide_} \\right] $$\n    The $E2$ enzyme then catalyzes the transfer of this acetyl group from the lipoamide arm to coenzyme A, forming the final product, acetyl-CoA.\n    $$ \\left[ \\text{_acetyl-dihydrolipoamide_} \\right] + \\mathrm{CoA}\\text{-}\\mathrm{SH} \\longrightarrow \\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{S}\\text{-}\\mathrm{CoA} + \\text{Lipoamide}_{red} $$\n    The resulting acetyl-CoA molecule ($\\mathrm{CH}_{3}\\text{-}\\mathrm{CO}\\text{-}\\mathrm{S}\\text{-}\\mathrm{CoA}$) is formed from the original $C\\text{-}2$ and $C\\text{-}3$ of pyruvate. The methyl carbon of acetyl-CoA derives from $C\\text{-}3$ of pyruvate, and the carbonyl carbon derives from $C\\text{-}2$ of pyruvate. Since neither $C\\text{-}2$ nor $C\\text{-}3$ was labeled, the acetyl-CoA product is unlabeled.\n\n3.  **Reaction on Dihydrolipoyl Dehydrogenase ($E3$): Regeneration**\n    The $E3$ subunit reoxidizes the reduced lipoamide ($\\text{Lipoamide}_{red}$) using FAD and $\\mathrm{NAD}^{+}$, regenerating the complex for another catalytic cycle. This step does not involve the carbon skeleton derived from pyruvate and is irrelevant to the distribution of the ${}^{14}\\mathrm{C}$ label.\n\n**Conclusion of Derivation:**\nThe mechanism of the pyruvate dehydrogenase complex dictates that the $C\\text{-}1$ (carboxyl) carbon of pyruvate is irreversibly lost as $\\mathrm{CO}_{2}$ in the first step of the reaction. The remaining two carbons, $C\\text{-}2$ and $C\\text{-}3$, form the acetyl group of acetyl-CoA. Consequently, when using $[1\\text{-}{}^{14}\\mathrm{C}]$pyruvate, the radioactive label appears exclusively in the $\\mathrm{CO}_{2}$ product.\n\n**Evaluation of Provided Options:**\n\nA. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in $\\mathrm{CO}_{2}$; the acetyl–CoA is unlabeled.\nThis statement is a direct consequence of the established reaction mechanism. The decarboxylation of the $C\\text{-}1$ carbon is the initial and irreversible chemical event concerning the carbon skeleton.\nVerdict: **Correct**.\n\nB. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in the carbonyl carbon of acetyl–CoA.\nThis is incorrect. The carbonyl carbon of acetyl-CoA is derived from the $C\\text{-}2$ keto carbon of pyruvate. For the label to appear here, the substrate would need to be $[2\\text{-}{}^{14}\\mathrm{C}]$pyruvate.\nVerdict: **Incorrect**.\n\nC. The $\\;{}^{14}\\mathrm{C}\\;$ label appears exclusively in the methyl carbon of acetyl–CoA.\nThis is incorrect. The methyl carbon of acetyl-CoA is derived from the $C\\text{-}3$ methyl carbon of pyruvate. For the label to appear here, the substrate would need to be $[3\\text{-}{}^{14}\\mathrm{C}]$pyruvate.\nVerdict: **Incorrect**.\n\nD. The $\\;{}^{14}\\mathrm{C}\\;$ label partitions between $\\mathrm{CO}_{2}$ and acetyl–CoA due to equilibration during the $E1$ step.\nThis is mechanistically baseless. The enzymatic reaction is stereospecific and proceeds through a defined sequence of covalent intermediates. There is no plausible mechanism for an equilibration or \"scrambling\" of the carboxyl carbon with the other two carbons of the pyruvate backbone. The decarboxylation is a committed and irreversible step.\nVerdict: **Incorrect**.", "answer": "$$\\boxed{A}$$", "id": "2595865"}, {"introduction": "Effective metabolic control requires feedback from downstream products to modulate the activity of upstream enzymes. The PDC is exquisitely regulated by the levels of its products, acetyl-CoA and NADH. This exercise moves from a qualitative understanding of the reaction to a quantitative analysis of its control, focusing on product inhibition at the dihydrolipoyl transacetylase (E2) active site. By applying the principles of competitive inhibition, you will calculate how acetyl-CoA accumulation directly alters the kinetic parameters of the E2 enzyme, providing a tangible link between metabolic state and enzymatic activity [@problem_id:2595803].", "problem": "In the mitochondrial pyruvate dehydrogenase complex, the dihydrolipoamide acetyltransferase component (E2) transfers the acetyl group to coenzyme A (CoA), producing acetyl-coenzyme A (acetyl-CoA). Product accumulation of acetyl-CoA is known to regulate the complex by binding at the CoA interaction site on E2. Consider an isolated E2 module that, in the absence of product, follows a one-substrate Michaelis–Menten scheme with CoA as the substrate. Assume rapid-equilibrium binding for inhibitor and substrate and a single active site per enzyme. Under these assumptions, product (acetyl-CoA) binds competitively to the free enzyme at the CoA site.\n\nAn experiment determines the following parameters in the absence of acetyl-CoA: the Michaelis constant for CoA is $K_{m} = 15\\,\\mu\\mathrm{M}$ and the maximal velocity is $V_{\\max} = 120\\,\\mu\\mathrm{mol}\\,\\mathrm{min}^{-1}\\,\\mathrm{mg}^{-1}$. Independent binding measurements give the dissociation constant of acetyl-CoA for the E2 CoA site as $K_{i} = 25\\,\\mu\\mathrm{M}$. In a physiological perturbation, the mitochondrial acetyl-CoA concentration rises to $[I] = 75\\,\\mu\\mathrm{M}$.\n\nStarting from mass-action binding and the steady-state description of a one-substrate enzyme with a competitive inhibitor at the substrate-binding site, determine the apparent Michaelis constant for CoA, $K_{m,\\mathrm{app}}$, and the apparent maximal velocity, $V_{\\max,\\mathrm{app}}$, for E2 at the stated acetyl-CoA concentration. Express $K_{m,\\mathrm{app}}$ in $\\mu\\mathrm{M}$ and $V_{\\max,\\mathrm{app}}$ in $\\mu\\mathrm{mol}\\,\\mathrm{min}^{-1}\\,\\mathrm{mg}^{-1}$. Provide your final answer as a single row matrix $\\bigl[K_{m,\\mathrm{app}},\\,V_{\\max,\\mathrm{app}}\\bigr]$. No rounding is required.", "solution": "The pyruvate dehydrogenase complex contains three core enzymes: pyruvate dehydrogenase (E1), dihydrolipoamide acetyltransferase (E2), and dihydrolipoamide dehydrogenase (E3). The E2 component catalyzes the transfer of an acetyl group from its lipoamide arm to coenzyme A (CoA) to form acetyl-coenzyme A (acetyl-CoA). Product regulation can occur via binding of acetyl-CoA to the CoA site on E2, thereby competing with CoA for access to the active site.\n\nWe begin with the Michaelis–Menten framework for a one-substrate enzyme. Let $E$ denote free enzyme, $S$ the substrate (CoA), $ES$ the enzyme–substrate complex, and $I$ the inhibitor (acetyl-CoA). The binding schemes are\n$$\nE + S \\rightleftharpoons ES, \\quad E + I \\rightleftharpoons EI,\n$$\nwith the inhibitor competing for the same binding site as the substrate. We assume rapid-equilibrium binding for $I$ and use the steady-state assumption for $ES$. Define the Michaelis constant $K_{m}$ by\n$$\nK_{m} = \\frac{k_{-1} + k_{\\mathrm{cat}}}{k_{1}},\n$$\nand the inhibitor dissociation constant $K_{i}$ by\n$$\nK_{i} = \\frac{[E][I]}{[EI]}.\n$$\nThe total enzyme concentration is\n$$\n[E]_{\\mathrm{T}} = [E] + [ES] + [EI].\n$$\nUnder rapid-equilibrium for both binding steps, we can write\n$$\n[ES] = \\frac{[E][S]}{K_{m}}, \\qquad [EI] = \\frac{[E][I]}{K_{i}}.\n$$\nHence,\n$$\n[E]_{\\mathrm{T}} = [E]\\left(1 + \\frac{[S]}{K_{m}} + \\frac{[I]}{K_{i}}\\right).\n$$\nSolving for $[E]$ gives\n$$\n[E] = \\frac{[E]_{\\mathrm{T}}}{1 + \\frac{[S]}{K_{m}} + \\frac{[I]}{K_{i}}}.\n$$\nThen\n$$\n[ES] = \\frac{[E][S]}{K_{m}} = \\frac{[E]_{\\mathrm{T}}\\,[S]}{K_{m}\\left(1 + \\frac{[S]}{K_{m}} + \\frac{[I]}{K_{i}}\\right)} = \\frac{[E]_{\\mathrm{T}}\\,[S]}{K_{m}\\left(1 + \\frac{[I]}{K_{i}}\\right) + [S]}.\n$$\nThe steady-state velocity is\n$$\nv = k_{\\mathrm{cat}}[ES] = V_{\\max}\\,\\frac{[S]}{K_{m}\\left(1 + \\frac{[I]}{K_{i}}\\right) + [S]},\n$$\nwhere $V_{\\max} = k_{\\mathrm{cat}}[E]_{\\mathrm{T}}$. Comparing this to the Michaelis–Menten form $v = V_{\\max,\\mathrm{app}}\\,\\dfrac{[S]}{K_{m,\\mathrm{app}} + [S]}$, we identify\n$$\nK_{m,\\mathrm{app}} = K_{m}\\left(1 + \\frac{[I]}{K_{i}}\\right), \\qquad V_{\\max,\\mathrm{app}} = V_{\\max}.\n$$\n\nWe now substitute the given values. The factor multiplying $K_{m}$ is\n$$\n1 + \\frac{[I]}{K_{i}} = 1 + \\frac{75\\,\\mu\\mathrm{M}}{25\\,\\mu\\mathrm{M}} = 1 + 3 = 4.\n$$\nTherefore,\n$$\nK_{m,\\mathrm{app}} = \\left(15\\,\\mu\\mathrm{M}\\right)\\times 4 = 60\\,\\mu\\mathrm{M},\n$$\nand\n$$\nV_{\\max,\\mathrm{app}} = 120\\,\\mu\\mathrm{mol}\\,\\mathrm{min}^{-1}\\,\\mathrm{mg}^{-1}.\n$$\n\nThus, the presence of acetyl-coenzyme A at $[I] = 75\\,\\mu\\mathrm{M}$ increases the apparent Michaelis constant for CoA by a factor of $4$ while leaving the maximal velocity unchanged. The requested row matrix is $\\bigl[60,\\,120\\bigr]$ with the stated units.", "answer": "$$\\boxed{\\begin{pmatrix}60 & 120\\end{pmatrix}}$$", "id": "2595803"}, {"introduction": "Beyond immediate feedback inhibition, the PDC is governed by a sophisticated layer of covalent modification that integrates numerous signals reflecting the cell's overall energy status. This regulation is achieved through a dynamic balance between the activities of Pyruvate Dehydrogenase Kinase (PDK) and Pyruvate Dehydrogenase Phosphatase (PDP). This final practice challenges you to model this regulatory switch, deriving the steady-state active fraction of the complex from the competing rates of phosphorylation and dephosphorylation. This exercise bridges the gap between individual molecular interactions and the systems-level logic of metabolic control [@problem_id:2595862].", "problem": "A mitochondrially localized Pyruvate Dehydrogenase Complex (PDC) toggles between a catalytically active, dephosphorylated state and an inactive, phosphorylated state. The interconversion is governed by Pyruvate Dehydrogenase Kinase (PDK), which phosphorylates the E1 subunit and inactivates PDC, and Pyruvate Dehydrogenase Phosphatase (PDP), which dephosphorylates and activates PDC. Assume a two-state model in which the fraction of active PDC is $a(t)$ and the fraction of inactive PDC is $i(t)$, with $a(t)+i(t)=1$. Assume pseudo-first-order kinetics for the interconversion, with an effective inactivation rate $v_{PDK}$ and an effective reactivation rate $v_{PDP}$, each depending on regulators through saturating factors.\n\nYou are given the following regulator-dependent forms for the effective rate coefficients:\n$$\nv_{PDK} \\;=\\; k_{PDK}^{0}\\,\\underbrace{\\left(1+\\alpha_{NADH}\\,\\frac{[\\mathrm{NADH}]}{K_{a,NADH}+[\\mathrm{NADH}]}\\right)}_{\\text{activation by NADH}}\\,\\underbrace{\\left(1+\\alpha_{AcCoA}\\,\\frac{[\\mathrm{AcCoA}]}{K_{a,AcCoA}+[\\mathrm{AcCoA}]}\\right)}_{\\text{activation by AcCoA}}\\,\\underbrace{\\frac{1}{1+\\left(\\frac{[\\mathrm{Pyruvate}]}{K_{i,Pyr}}\\right)^{h_{Pyr}}}}_{\\text{inhibition by pyruvate}}\\,\\underbrace{\\frac{1}{1+\\frac{[\\mathrm{ADP}]}{K_{i,ADP}}}}_{\\text{inhibition by ADP}},\n$$\n$$\nv_{PDP} \\;=\\; k_{PDP}^{0}\\,\\underbrace{\\left(1+\\beta_{Ca}\\,\\frac{[\\mathrm{Ca}^{2+}]}{K_{a,Ca}+[\\mathrm{Ca}^{2+}]}\\right)}_{\\text{activation by Ca}^{2+}}.\n$$\n\nHere $k_{PDK}^{0}$ and $k_{PDP}^{0}$ are baseline first-order rate constants. Nicotinamide Adenine Dinucleotide (reduced form, NADH), Acetyl-Coenzyme A (AcCoA), pyruvate, and Adenosine Diphosphate (ADP) regulate PDK as noted. Calcium ions $\\mathrm{Ca}^{2+}$ activate PDP, reflecting coupling of PDC activation to excitation-contraction in tissues such as heart and skeletal muscle.\n\nTask:\n1) Starting from conservation of total PDC and mass-action interconversion between the two states, derive an expression for the steady-state active fraction $f_{active}$ in terms of $v_{PDK}$ and $v_{PDP}$.\n\n2) Using your derived expression, compute $f_{active}$ for the following mitochondrial conditions and parameters:\n- $k_{PDK}^{0}=0.08\\ \\mathrm{s}^{-1}$, $k_{PDP}^{0}=0.06\\ \\mathrm{s}^{-1}$.\n- $[\\mathrm{NADH}]=0.3\\ \\mathrm{mM}$, $K_{a,NADH}=0.1\\ \\mathrm{mM}$, $\\alpha_{NADH}=3$.\n- $[\\mathrm{AcCoA}]=0.10\\ \\mathrm{mM}$, $K_{a,AcCoA}=0.05\\ \\mathrm{mM}$, $\\alpha_{AcCoA}=2$.\n- $[\\mathrm{Pyruvate}]=0.50\\ \\mathrm{mM}$, $K_{i,Pyr}=0.20\\ \\mathrm{mM}$, $h_{Pyr}=2$.\n- $[\\mathrm{ADP}]=0.50\\ \\mathrm{mM}$, $K_{i,ADP}=0.20\\ \\mathrm{mM}$.\n- $[\\mathrm{Ca}^{2+}]=0.80\\ \\mu\\mathrm{M}$, $K_{a,Ca}=0.30\\ \\mu\\mathrm{M}$, $\\beta_{Ca}=5$.\n\nReport the final value of $f_{active}$ as a unitless decimal, rounded to four significant figures.", "solution": "We begin from a two-state interconversion model that treats the active, dephosphorylated PDC as one state and the inactive, phosphorylated PDC as another. Let $a(t)$ denote the fraction of total PDC in the active state and $i(t)$ the fraction in the inactive state. Conservation of the total enzyme implies $a(t)+i(t)=1$ for all $t$.\n\nAssume pseudo-first-order kinetics for the interconversion with effective rate coefficients $v_{PDK}$ for active $\\to$ inactive (phosphorylation by Pyruvate Dehydrogenase Kinase) and $v_{PDP}$ for inactive $\\to$ active (dephosphorylation by Pyruvate Dehydrogenase Phosphatase). Then the time evolution of $a(t)$ is given by the net influx from the inactive state minus the efflux to the inactive state:\n$$\n\\frac{da}{dt} \\;=\\; v_{PDP}\\,i(t)\\;-\\;v_{PDK}\\,a(t).\n$$\nUsing $i(t)=1-a(t)$ from conservation,\n$$\n\\frac{da}{dt} \\;=\\; v_{PDP}\\,(1-a)\\;-\\;v_{PDK}\\,a \\;=\\; v_{PDP} - (v_{PDK}+v_{PDP})\\,a.\n$$\nAt steady state, $\\frac{da}{dt}=0$, so\n$$\n0 \\;=\\; v_{PDP} - (v_{PDK}+v_{PDP})\\,a_{\\ast},\n$$\nwhich yields\n$$\na_{\\ast} \\;=\\; \\frac{v_{PDP}}{v_{PDK}+v_{PDP}}.\n$$\nThus the steady-state active fraction is\n$$\nf_{active} \\;=\\; \\frac{v_{PDP}}{v_{PDK}+v_{PDP}}.\n$$\n\nNext, we compute $v_{PDK}$ and $v_{PDP}$ from the given regulator-dependent forms and parameter values.\n\nCompute each regulatory factor for $v_{PDK}$:\n- Activation by Nicotinamide Adenine Dinucleotide (reduced form, NADH):\n$$\n1+\\alpha_{NADH}\\,\\frac{[\\mathrm{NADH}]}{K_{a,NADH}+[\\mathrm{NADH}]} \\;=\\; 1 + 3\\,\\frac{0.3}{0.1+0.3} \\;=\\; 1 + 3\\,\\frac{0.3}{0.4} \\;=\\; 1 + 3\\cdot 0.75 \\;=\\; 3.25.\n$$\n- Activation by Acetyl-Coenzyme A (AcCoA):\n$$\n1+\\alpha_{AcCoA}\\,\\frac{[\\mathrm{AcCoA}]}{K_{a,AcCoA}+[\\mathrm{AcCoA}]} \\;=\\; 1 + 2\\,\\frac{0.10}{0.05+0.10} \\;=\\; 1 + 2\\,\\frac{0.10}{0.15} \\;=\\; 1 + 2\\cdot\\frac{2}{3} \\;=\\; \\frac{7}{3}\\;\\approx\\;2.333\\ldots\n$$\n- Inhibition by pyruvate with Hill coefficient $h_{Pyr}=2$:\n$$\n\\frac{1}{1+\\left(\\frac{[\\mathrm{Pyruvate}]}{K_{i,Pyr}}\\right)^{h_{Pyr}}} \\;=\\; \\frac{1}{1+\\left(\\frac{0.50}{0.20}\\right)^{2}} \\;=\\; \\frac{1}{1+(2.5)^{2}} \\;=\\; \\frac{1}{1+6.25} \\;=\\; \\frac{1}{7.25} \\;=\\; \\frac{4}{29}.\n$$\n- Inhibition by Adenosine Diphosphate (ADP):\n$$\n\\frac{1}{1+\\frac{[\\mathrm{ADP}]}{K_{i,ADP}}} \\;=\\; \\frac{1}{1+\\frac{0.50}{0.20}} \\;=\\; \\frac{1}{1+2.5} \\;=\\; \\frac{1}{3.5} \\;=\\; \\frac{2}{7}.\n$$\n\nMultiply these factors to get the net modulation of $k_{PDK}^{0}$:\n$$\n\\left(3.25\\right)\\left(\\frac{7}{3}\\right)\\left(\\frac{4}{29}\\right)\\left(\\frac{2}{7}\\right)\n\\;=\\; \\frac{13}{4}\\cdot\\frac{7}{3}\\cdot\\frac{4}{29}\\cdot\\frac{2}{7}\n\\;=\\; \\frac{91}{12}\\cdot\\frac{4}{29}\\cdot\\frac{2}{7}\n\\;=\\; \\frac{26}{87}.\n$$\nTherefore,\n$$\nv_{PDK} \\;=\\; k_{PDK}^{0}\\cdot \\frac{26}{87} \\;=\\; 0.08\\ \\mathrm{s}^{-1}\\cdot \\frac{26}{87} \\;=\\; \\frac{2.08}{87}\\ \\mathrm{s}^{-1} \\;\\approx\\; 0.023908\\ \\mathrm{s}^{-1}.\n$$\n\nNow compute $v_{PDP}$:\n- Activation by calcium:\n$$\n1+\\beta_{Ca}\\,\\frac{[\\mathrm{Ca}^{2+}]}{K_{a,Ca}+[\\mathrm{Ca}^{2+}]} \\;=\\; 1 + 5\\,\\frac{0.80}{0.30+0.80} \\;=\\; 1 + 5\\,\\frac{0.80}{1.10} \\;=\\; 1 + 5\\cdot\\frac{8}{11} \\;=\\; 1 + \\frac{40}{11} \\;=\\; \\frac{51}{11}.\n$$\nTherefore,\n$$\nv_{PDP} \\;=\\; k_{PDP}^{0}\\cdot \\frac{51}{11} \\;=\\; 0.06\\ \\mathrm{s}^{-1}\\cdot \\frac{51}{11} \\;=\\; \\frac{3.06}{11}\\ \\mathrm{s}^{-1} \\;\\approx\\; 0.278182\\ \\mathrm{s}^{-1}.\n$$\n\nFinally, the steady-state active fraction is\n$$\nf_{active} \\;=\\; \\frac{v_{PDP}}{v_{PDK}+v_{PDP}} \\;=\\; \\frac{\\frac{3.06}{11}}{\\frac{2.08}{87}+\\frac{3.06}{11}} \\;=\\; \\frac{13311}{14455} \\;\\approx\\; 0.9208936.\n$$\n\nRounded to four significant figures as a unitless decimal:\n$$\nf_{active} \\;\\approx\\; 0.9209.\n$$", "answer": "$$\\boxed{0.9209}$$", "id": "2595862"}]}